Ryman Healthcare (NZSE: RYM) Shares Rise 19% in Quarter, Long-Term Holders Down 81%
- Quarterly Share Price Recovery: Ryman Healthcare's share price increased by 19% in the last quarter; however, long-term holders have faced an 81% decline over the past five years, highlighting a contradiction between short-term gains and long-term value erosion.
- Revenue Growth Analysis: Despite a 13% annual revenue growth rate over the last five years, the company has not been profitable, resulting in a 13% annual stock price decline, reflecting market concerns about its future profitability.
- Shareholder Return Discrepancy: Ryman Healthcare's total shareholder return (TSR) dropped by 77% over the past five years; although the stock price has performed poorly, the impact of reinvested dividends mitigates the decline, indicating the supportive role of dividends.
- Market Performance Comparison: Over the past year, Ryman Healthcare shareholders lost 31%, while the broader market gained 5.6%, indicating the company's performance significantly lags behind the market average, which may affect investor confidence.
Discover Tomorrow's Bullish Stocks Today
Analyst Views on RYM
About RYM
About the author

Ryman Healthcare (NZSE: RYM) Shares Rise 19% in Quarter, Long-Term Holders Down 81%
- Quarterly Share Price Recovery: Ryman Healthcare's share price increased by 19% in the last quarter; however, long-term holders have faced an 81% decline over the past five years, highlighting a contradiction between short-term gains and long-term value erosion.
- Revenue Growth Analysis: Despite a 13% annual revenue growth rate over the last five years, the company has not been profitable, resulting in a 13% annual stock price decline, reflecting market concerns about its future profitability.
- Shareholder Return Discrepancy: Ryman Healthcare's total shareholder return (TSR) dropped by 77% over the past five years; although the stock price has performed poorly, the impact of reinvested dividends mitigates the decline, indicating the supportive role of dividends.
- Market Performance Comparison: Over the past year, Ryman Healthcare shareholders lost 31%, while the broader market gained 5.6%, indicating the company's performance significantly lags behind the market average, which may affect investor confidence.

What Caused RYTHM (RYM) Stock to Surge More Than 23% Overnight?
Stock Performance: RYTHM Inc. shares rose 23.3% in after-hours trading to $30, despite a 21.52% drop during regular trading, closing at $24.33. The stock has seen a 46.54% decline over the past month.
Q3 Financial Results: The company reported a 98% increase in third-quarter revenue from continuing operations, reaching $4 million, while ending the quarter with $35.6 million in cash despite an $8.9 million operating loss.
Retail Expansion: RYTHM's THC beverage, Señorita THC Margaritas, launched in over 1,000 Circle K stores and select Target locations, marking significant retail expansion for hemp-derived THC products.
Strategic Developments: The company acquired intellectual property for several iconic brands and rebranded from Agrify Corporation to RYTHM Inc., positioning itself to benefit from the growing acceptance of THC beverages among consumers.









